Cargando…
Nucleic Acid–Based Therapeutics in Orphan Neurological Disorders: Recent Developments
The possibility of rational design and the resulting faster and more cost-efficient development cycles of nucleic acid–based therapeutics (NBTs), such as antisense oligonucleotides, siRNAs, and gene therapy vectors, have fueled increased activity in developing therapies for orphan diseases. Despite...
Autores principales: | Khorkova, Olga, Hsiao, Jane, Wahlestedt, Claes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115123/ https://www.ncbi.nlm.nih.gov/pubmed/33996898 http://dx.doi.org/10.3389/fmolb.2021.643681 |
Ejemplares similares
-
Nucleic acid-based therapeutics for the treatment of central nervous system disorders
por: McCartan, Robyn, et al.
Publicado: (2023) -
Natural antisense transcripts as drug targets
por: Khorkova, Olga, et al.
Publicado: (2022) -
Editorial: Recent breakthroughs in the decoding of circulating nucleic acids and their applications to human diseases
por: El-Daly, Sherien M., et al.
Publicado: (2023) -
Editorial: Coarse-Grained Models of Nucleic Acids and Their Applications
por: Maciejczyk, Maciej
Publicado: (2022) -
Editorial: Structural biology of nucleic acid replication, recombination and repair
por: Bolt, Edward L., et al.
Publicado: (2023)